Abstract:BackgroundThis paper presents the use of Support Vector Machines (SVMs) for prediction and analysis of antisense oligonucleotide (AO) efficacy. The collected database comprises 315 AO molecules including 68 features each, inducing a problem well-suited to SVMs. The task of feature selection is crucial given the presence of noisy or redundant features, and the well-known problem of the curse of dimensionality. We propose a two-stage strategy to develop an optimal model: (1) feature selection using correlation analysis, mutual information, and SVM-based recursive feature elimination (SVM-RFE), and (2) AO prediction using standard and profiled SVM formulations. A profiled SVM gives different weights to different parts of the training data to focus the training on the most important regions.ResultsIn the first stage, the SVM-RFE technique was most efficient and robust in the presence of low number of samples and high input space dimension. This method yielded an optimal subset of 14 representative features, which were all related to energy and sequence motifs. The second stage evaluated the performance of the predictors (overall correlation coefficient between observed and predicted efficacy, r; mean error, ME; and root-mean-square-error, RMSE) using 8-fold and minus-one-RNA cross-validation methods. The profiled SVM produced the best results (r = 0.44, ME = 0.022, and RMSE= 0.278) and predicted high (>75% inhibition of gene expression) and low efficacy (<25%) AOs with a success rate of 83.3% and 82.9%, respectively, which is better than by previous approaches. A web server for AO prediction is available online at http://aosvm.cgb.ki.se/.ConclusionsThe SVM approach is well suited to the AO prediction problem, and yields a prediction accuracy superior to previous methods. The profiled SVM was found to perform better than the standard SVM, suggesting that it could lead to improvements in other prediction problems as well.

Prediction of P2Y12 Antagonists Using a Novel Genetic Algorithm-Support Vector Machine Coupled Approach.

Predicting the Androgenicity of Structurally Diverse Compounds from Molecular Structure Using Different Classifiers

Using Support Vector Regression Coupled with the Genetic Algorithm for Predicting Acute Toxicity to the Fathead Minnow

Identifying P-Glycoprotein Substrates Using a Support Vector Machine Optimized by a Particle Swarm.

Classification of 5-HT(1A) Receptor Agonists and Antagonists Using GA-SVM Method.

Prediction of P-Glycoprotein Substrates by a Support Vector Machine Approach

QSAR study of fiavonoids derivatives as p56lck protein tyrosine kinase inhibitors using GA-SVM

Prediction of the Aquatic Toxicity of Aromatic Compounds to Tetrahymena Pyriformis Through Support Vector Regression

Quantitative Structure–activity Relationship Study of Influenza Virus Neuraminidase A/PR/8/34 (H1N1) Inhibitors by Genetic Algorithm Feature Selection and Support Vector Regression

Feature Selection and Activity Prediction in Chinese Medicine Research Using a Hybrid Model GA-SVM.

Classification of 5-Ht1a Receptor Ligands on the Basis of Their Binding Affinities by Using Pso-Adaboost-Svm

Mutation Probability of Cytochrome P450 Based on a Genetic Algorithm and Support Vector Machine.

Machine learning-aided search for ligands of P2Y6 and other P2Y receptors

An in Silico Approach for Screening Flavonoids As P-glycoprotein Inhibitors Based on a Bayesian-regularized Neural Network

1. Applications of Genetic Algorithms to the Prediction of Blood-Brain Partitioning of a Large Set of Drugs

In silico identification of human pregnane X receptor activators from molecular descriptors by machine learning approaches

QSAR Studies of Imidazopyridine Derivatives As Et-PKG Inhibitors Using the PSO-SVM Approach

QSAR study on applying support vector machine to binding affinity of Ah receptor with aromatic compounds

In Silico Prediction of Blood–Brain Partitioning Using a Chemometric Method Called Genetic Algorithm Based Variable Selection

QSAR analysis of VEGFR-2 inhibitors based on machine learning, Topomer CoMFA and molecule docking

Profiled support vector machines for antisense oligonucleotide efficacy prediction